Liver study tests drug safety for future patients
NCT ID NCT05440344
Summary
This study aimed to understand how a breast cancer drug, imlunestrant, is processed by the body in people with different levels of liver function. It compared the drug's levels in the blood of women with impaired livers to those with healthy livers. The goal was to gather safety information to help guide future dosing for patients with liver problems.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
American Research Corporation at Texas Liver Institute
San Antonio, Texas, 78215, United States
-
Inland Empire Liver Foundation
Rialto, California, 92377, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
Conditions
Explore the condition pages connected to this study.